APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sacral Neuromodulation Device

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Sacral Neuromodulation Device Industry Growth and Trends Forecast to 2032

4 July 202696 pages

Choose your research edition.

Industry ResearchSacral Neuromodulation Device Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Sacral Neuromodulation Device Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Sacral Neuromodulation Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sacral Neuromodulation Device Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Sacral Neuromodulation Device Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Sacral Neuromodulation Device market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Sacral Neuromodulation Device is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Sacral Neuromodulation Device is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sacral Neuromodulation Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Sacral Neuromodulation Device include Axonics (Boston Scientific), Neuspera, General Stim (Nurotron), Medtronic and PINS Medical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Sacral Neuromodulation Device market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Sacral Neuromodulation Device market size, estimates, and forecasts are presented in terms of sales volume (units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Sacral Neuromodulation Device market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Sacral Neuromodulation Device.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Sacral Neuromodulation Device market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Sacral Neuromodulation Device Market by Company

Axonics (Boston Scientific)

Neuspera

General Stim (Nurotron)

Medtronic

PINS Medical

Sacral Neuromodulation Device Segment by Type

Rechargeable

Recharge-free

Sacral Neuromodulation Device Segment by Application

Hospitals

ASCs

Sacral Neuromodulation Device Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sacral Neuromodulation Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sacral Neuromodulation Device and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sacral Neuromodulation Device.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Sacral Neuromodulation Device manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Sacral Neuromodulation Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Rechargeable Table 2. Major Company of Recharge-free Table 3. Global Sacral Neuromodulation Device Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Sacral Neuromodulation Device Sales by Type (2021-2026) & (units) Table 5. Global Sacral Neuromodulation Device Sales Market Share in Volume by Type (2021-2026) Table 6. Global Sacral Neuromodulation Device Sales by Type (2021-2026) & (US$ Million) Table 7. Global Sacral Neuromodulation Device Sales Market Share in Value by Type (2021-2026) Table 8. Global Sacral Neuromodulation Device Price by Type (2021-2026) & (USD/unit) Table 9. Global Sacral Neuromodulation Device Sales by Type (2027-2032) & (units) Table 10. Global Sacral Neuromodulation Device Sales Market Share in Volume by Type (2027-2032) Table 11. Global Sacral Neuromodulation Device Sales by Type (2027-2032) & (US$ Million) Table 12. Global Sacral Neuromodulation Device Sales Market Share in Value by Type (2027-2032) Table 13. Global Sacral Neuromodulation Device Price by Type (2027-2032) & (USD/unit) Table 14. North America Sacral Neuromodulation Device Sales by Type (2021-2026) & (units) Table 15. North America Sacral Neuromodulation Device Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Sacral Neuromodulation Device Sales by Type (2021-2026) & (units) Table 17. Europe Sacral Neuromodulation Device Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Sacral Neuromodulation Device Sales by Type (2021-2026) & (units) Table 19. Asia-Pacific Sacral Neuromodulation Device Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Sacral Neuromodulation Device Sales by Type (2021-2026) & (units) Table 21. Latin America Sacral Neuromodulation Device Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Sacral Neuromodulation Device Sales by Type (2021-2026) & (units) Table 23. Middle East and Africa Sacral Neuromodulation Device Sales by Type (2021-2026) & (US$ Million) Table 24. Sacral Neuromodulation Device Industry Trends Table 25. Sacral Neuromodulation Device Industry Drivers Table 26. Sacral Neuromodulation Device Industry Opportunities and Challenges Table 27. Sacral Neuromodulation Device Industry Restraints Table 28. Global Sacral Neuromodulation Device Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Sacral Neuromodulation Device Revenue Market Share by Company (2021-2026) Table 30. Global Sacral Neuromodulation Device Sales by Company (2021-2026) & (units) Table 31. Global Sacral Neuromodulation Device Sales Share by Company (2021-2026) Table 32. Global Sacral Neuromodulation Device Market Price by Company (2021-2026) & (USD/unit) Table 33. Global Sacral Neuromodulation Device Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Sacral Neuromodulation Device Major Company Production Sites and Headquarters Table 35. Global Sacral Neuromodulation Device Company, Product Type & Application Table 36. Global Sacral Neuromodulation Device Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Sacral Neuromodulation Device by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Sacral Neuromodulation Device Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Sacral Neuromodulation Device Sales by Region (2021-2026) & (units) Table 41. Global Sacral Neuromodulation Device Sales Market Share in Volume by Region (2021-2026) Table 42. Global Sacral Neuromodulation Device Sales by Region (2021-2026) & (US$ Million) Table 43. Global Sacral Neuromodulation Device Sales Market Share in Value by Region (2021-2026) Table 44. Global Sacral Neuromodulation Device Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 45. Global Sacral Neuromodulation Device Sales by Region (2027-2032) & (units) Table 46. Global Sacral Neuromodulation Device Sales Market Share in Volume by Region (2027-2032) Table 47. Global Sacral Neuromodulation Device Sales by Region (2027-2032) & (US$ Million) Table 48. Global Sacral Neuromodulation Device Sales Market Share in Value by Region (2027-2032) Table 49. Global Sacral Neuromodulation Device Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2027-2032) Table 50. Global Sacral Neuromodulation Device Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Sacral Neuromodulation Device Sales by Application (2021-2026) & (units) Table 52. Global Sacral Neuromodulation Device Sales Market Share in Volume by Application (2021-2026) Table 53. Global Sacral Neuromodulation Device Sales by Application (2021-2026) & (US$ Million) Table 54. Global Sacral Neuromodulation Device Sales Market Share in Value by Application (2021-2026) Table 55. Global Sacral Neuromodulation Device Price by Application (2021-2026) & (USD/unit) Table 56. Global Sacral Neuromodulation Device Sales by Application (2027-2032) & (units) Table 57. Global Sacral Neuromodulation Device Sales Market Share in Volume by Application (2027-2032) Table 58. Global Sacral Neuromodulation Device Sales by Application (2027-2032) & (US$ Million) Table 59. Global Sacral Neuromodulation Device Sales Market Share in Value by Application (2027-2032) Table 60. Global Sacral Neuromodulation Device Price by Application (2027-2032) & (USD/unit) Table 61. North America Sacral Neuromodulation Device Sales by Application (2021-2026) & (units) Table 62. North America Sacral Neuromodulation Device Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Sacral Neuromodulation Device Sales by Application (2021-2026) & (units) Table 64. Europe Sacral Neuromodulation Device Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Sacral Neuromodulation Device Sales by Application (2021-2026) & (units) Table 66. Asia-Pacific Sacral Neuromodulation Device Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Sacral Neuromodulation Device Sales by Application (2021-2026) & (units) Table 68. Latin America Sacral Neuromodulation Device Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Sacral Neuromodulation Device Sales by Application (2021-2026) & (units) Table 70. Middle East and Africa Sacral Neuromodulation Device Sales by Application (2021-2026) & (US$ Million) Table 71. Axonics (Boston Scientific) Company Information Table 72. Axonics (Boston Scientific) Business Overview Table 73. Axonics (Boston Scientific) Sacral Neuromodulation Device Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 74. Axonics (Boston Scientific) Sacral Neuromodulation Device Product Portfolio Table 75. Axonics (Boston Scientific) Recent Development Table 76. Neuspera Company Information Table 77. Neuspera Business Overview Table 78. Neuspera Sacral Neuromodulation Device Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 79. Neuspera Sacral Neuromodulation Device Product Portfolio Table 80. Neuspera Recent Development Table 81. General Stim (Nurotron) Company Information Table 82. General Stim (Nurotron) Business Overview Table 83. General Stim (Nurotron) Sacral Neuromodulation Device Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 84. General Stim (Nurotron) Sacral Neuromodulation Device Product Portfolio Table 85. General Stim (Nurotron) Recent Development Table 86. Medtronic Company Information Table 87. Medtronic Business Overview Table 88. Medtronic Sacral Neuromodulation Device Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. Medtronic Sacral Neuromodulation Device Product Portfolio Table 90. Medtronic Recent Development Table 91. PINS Medical Company Information Table 92. PINS Medical Business Overview Table 93. PINS Medical Sacral Neuromodulation Device Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. PINS Medical Sacral Neuromodulation Device Product Portfolio Table 95. PINS Medical Recent Development Table 96. North America Sacral Neuromodulation Device Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 97. North America Sacral Neuromodulation Device Sales by Country (2021-2026) & (units) Table 98. North America Sacral Neuromodulation Device Sales Market Share by Country (2021-2026) Table 99. North America Sacral Neuromodulation Device Sales Forecast by Country (2027-2032) & (units) Table 100. North America Sacral Neuromodulation Device Sales Market Share Forecast by Country (2027-2032) Table 101. North America Sacral Neuromodulation Device Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. North America Sacral Neuromodulation Device Market Size by Country (2021-2026) & (US$ Million) Table 103. North America Sacral Neuromodulation Device Market Share by Country (2021-2026) Table 104. North America Sacral Neuromodulation Device Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. North America Sacral Neuromodulation Device Market Share Forecast by Country (2027-2032) Table 106. Europe Sacral Neuromodulation Device Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 107. Europe Sacral Neuromodulation Device Sales by Country (2021-2026) & (units) Table 108. Europe Sacral Neuromodulation Device Sales Market Share by Country (2021-2026) Table 109. Europe Sacral Neuromodulation Device Sales Forecast by Country (2027-2032) & (units) Table 110. Europe Sacral Neuromodulation Device Sales Market Share Forecast by Country (2027-2032) Table 111. Europe Sacral Neuromodulation Device Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Europe Sacral Neuromodulation Device Market Size by Country (2021-2026) & (US$ Million) Table 113. Europe Sacral Neuromodulation Device Market Share by Country (2021-2026) Table 114. Europe Sacral Neuromodulation Device Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Europe Sacral Neuromodulation Device Market Share Forecast by Country (2027-2032) Table 116. Asia-Pacific Sacral Neuromodulation Device Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 117. Asia-Pacific Sacral Neuromodulation Device Sales by Country (2021-2026) & (units) Table 118. Asia-Pacific Sacral Neuromodulation Device Sales Market Share by Country (2021-2026) Table 119. Asia-Pacific Sacral Neuromodulation Device Sales Forecast by Country (2027-2032) & (units) Table 120. Asia-Pacific Sacral Neuromodulation Device Sales Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Sacral Neuromodulation Device Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Sacral Neuromodulation Device Market Size by Country (2021-2026) & (US$ Million) Table 123. Asia-Pacific Sacral Neuromodulation Device Market Share by Country (2021-2026) Table 124. Asia-Pacific Sacral Neuromodulation Device Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Asia-Pacific Sacral Neuromodulation Device Market Share Forecast by Country (2027-2032) Table 126. Latin America Sacral Neuromodulation Device Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 127. Latin America Sacral Neuromodulation Device Sales by Country (2021-2026) & (units) Table 128. Latin America Sacral Neuromodulation Device Sales Market Share by Country (2021-2026) Table 129. Latin America Sacral Neuromodulation Device Sales Forecast by Country (2027-2032) & (units) Table 130. Latin America Sacral Neuromodulation Device Sales Market Share Forecast by Country (2027-2032) Table 131. Latin America Sacral Neuromodulation Device Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Latin America Sacral Neuromodulation Device Market Size by Country (2021-2026) & (US$ Million) Table 133. Latin America Sacral Neuromodulation Device Market Share by Country (2021-2026) Table 134. Latin America Sacral Neuromodulation Device Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Latin America Sacral Neuromodulation Device Market Share Forecast by Country (2027-2032) Table 136. Middle East and Africa Sacral Neuromodulation Device Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 137. Middle East and Africa Sacral Neuromodulation Device Sales by Country (2021-2026) & (units) Table 138. Middle East and Africa Sacral Neuromodulation Device Sales Market Share by Country (2021-2026) Table 139. Middle East and Africa Sacral Neuromodulation Device Sales Forecast by Country (2027-2032) & (units) Table 140. Middle East and Africa Sacral Neuromodulation Device Sales Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Sacral Neuromodulation Device Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Sacral Neuromodulation Device Market Size by Country (2021-2026) & (US$ Million) Table 143. Middle East and Africa Sacral Neuromodulation Device Market Share by Country (2021-2026) Table 144. Middle East and Africa Sacral Neuromodulation Device Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Middle East and Africa Sacral Neuromodulation Device Market Share Forecast by Country (2027-2032) Table 146. Key Raw Materials Table 147. Raw Materials Key Suppliers Table 148. Sacral Neuromodulation Device Distributors List Table 149. Sacral Neuromodulation Device Customers List Table 150. Research Programs/Design for This Report Table 151. Authors List of This Report Table 152. Secondary Sources Table 153. Primary Sources List of Figures Figure 1. Sacral Neuromodulation Device Image Figure 2. Global Sacral Neuromodulation Device Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sacral Neuromodulation Device Market Size (2021-2032) & (US$ Million) Figure 4. Global Sacral Neuromodulation Device Sales (2021-2032) & (units) Figure 5. Rechargeable Image Figure 6. Global Rechargeable Sales YoY Growth (2021-2032) & (units) Figure 7. Recharge-free Image Figure 8. Global Recharge-free Sales YoY Growth (2021-2032) & (units) Figure 9. Global Sacral Neuromodulation Device Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Sacral Neuromodulation Device Market Share by Type 2025 VS 2032 Figure 11. North America Sacral Neuromodulation Device Sales Market Share in Volume by Type in 2025 Figure 12. North America Sacral Neuromodulation Device Sales Market Share in Value by Type in 2025 Figure 13. Europe Sacral Neuromodulation Device Sales Market Share in Volume by Type in 2025 Figure 14. Europe Sacral Neuromodulation Device Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Sacral Neuromodulation Device Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Sacral Neuromodulation Device Sales Market Share in Value by Type in 2025 Figure 17. Latin America Sacral Neuromodulation Device Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Sacral Neuromodulation Device Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Sacral Neuromodulation Device Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Sacral Neuromodulation Device Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Sacral Neuromodulation Device Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospitals Image Figure 24. Global Hospitals Sales YoY Growth (2021-2032) & (units) Figure 25. ASCs Image Figure 26. Global ASCs Sales YoY Growth (2021-2032) & (units) Figure 27. Global Sacral Neuromodulation Device Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Sacral Neuromodulation Device Market Share by Application 2025 VS 2032 Figure 29. North America Sacral Neuromodulation Device Sales Market Share in Volume by Application in 2025 Figure 30. North America Sacral Neuromodulation Device Sales Market Share in Value by Application in 2025 Figure 31. Europe Sacral Neuromodulation Device Sales Market Share in Volume by Application in 2025 Figure 32. Europe Sacral Neuromodulation Device Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Sacral Neuromodulation Device Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Sacral Neuromodulation Device Sales Market Share in Value by Application in 2025 Figure 35. Latin America Sacral Neuromodulation Device Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Sacral Neuromodulation Device Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Sacral Neuromodulation Device Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Sacral Neuromodulation Device Sales Market Share in Value by Application in 2025 Figure 39. North America Sacral Neuromodulation Device Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 40. North America Sacral Neuromodulation Device Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Sacral Neuromodulation Device Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Sacral Neuromodulation Device Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Sacral Neuromodulation Device Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 44. Europe Sacral Neuromodulation Device Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Sacral Neuromodulation Device Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Sacral Neuromodulation Device Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Sacral Neuromodulation Device Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 48. Asia-Pacific Sacral Neuromodulation Device Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Sacral Neuromodulation Device Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Sacral Neuromodulation Device Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Sacral Neuromodulation Device Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 52. Latin America Sacral Neuromodulation Device Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Sacral Neuromodulation Device Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Sacral Neuromodulation Device Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Sacral Neuromodulation Device Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 56. Middle East and Africa Sacral Neuromodulation Device Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Sacral Neuromodulation Device Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Sacral Neuromodulation Device Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Sacral Neuromodulation Device Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Sacral Neuromodulation Device Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Rechargeable
  • Recharge-free
Applications
  • Hospitals
  • ASCs
Companies covered
  • Axonics (Boston Scientific)
  • Neuspera
  • General Stim (Nurotron)
  • Medtronic
  • PINS Medical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Sacral Neuromodulation Device Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Sacral Neuromodulation Device Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Sacral Neuromodulation Device Market by Type
  6. 1.3.1 Rechargeable
  7. 1.3.2 Recharge-free
  8. 1.4 Global Sacral Neuromodulation Device Market Size by Type
  9. 1.4.1 Global Sacral Neuromodulation Device Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Sacral Neuromodulation Device Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Sacral Neuromodulation Device Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Sacral Neuromodulation Device Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Sacral Neuromodulation Device Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Sacral Neuromodulation Device Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Sacral Neuromodulation Device Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Sacral Neuromodulation Device Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Sacral Neuromodulation Device Industry Trends
  2. 2.2 Sacral Neuromodulation Device Industry Drivers
  3. 2.3 Sacral Neuromodulation Device Industry Opportunities and Challenges
  4. 2.4 Sacral Neuromodulation Device Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Sacral Neuromodulation Device Revenue (2021-2026)
  2. 3.2 Global Top Players by Sacral Neuromodulation Device Sales (2021-2026)
  3. 3.3 Global Top Players by Sacral Neuromodulation Device Price (2021-2026)
  4. 3.4 Global Sacral Neuromodulation Device Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Sacral Neuromodulation Device Major Company Production Sites & Headquarters
  6. 3.6 Global Sacral Neuromodulation Device Company, Product Type & Application
  7. 3.7 Global Sacral Neuromodulation Device Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Sacral Neuromodulation Device Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Sacral Neuromodulation Device Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Sacral Neuromodulation Device Tier 1, Tier 2, and Tier 3
4 Sacral Neuromodulation Device Regional Status and Outlook
  1. 4.1 Global Sacral Neuromodulation Device Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Sacral Neuromodulation Device Historic Market Size by Region
  3. 4.2.1 Global Sacral Neuromodulation Device Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Sacral Neuromodulation Device Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Sacral Neuromodulation Device Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Sacral Neuromodulation Device Forecasted Market Size by Region
  7. 4.3.1 Global Sacral Neuromodulation Device Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Sacral Neuromodulation Device Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Sacral Neuromodulation Device Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Sacral Neuromodulation Device by Application
  1. 5.1 Sacral Neuromodulation Device Market by Application
  2. 5.1.1 Hospitals
  3. 5.1.2 ASCs
  4. 5.2 Global Sacral Neuromodulation Device Market Size by Application
  5. 5.2.1 Global Sacral Neuromodulation Device Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Sacral Neuromodulation Device Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Sacral Neuromodulation Device Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Sacral Neuromodulation Device Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Sacral Neuromodulation Device Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Sacral Neuromodulation Device Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Sacral Neuromodulation Device Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Sacral Neuromodulation Device Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Axonics (Boston Scientific)
  2. 6.1.1 Axonics (Boston Scientific) Company Information
  3. 6.1.2 Axonics (Boston Scientific) Business Overview
  4. 6.1.3 Axonics (Boston Scientific) Sacral Neuromodulation Device Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Axonics (Boston Scientific) Sacral Neuromodulation Device Product Portfolio
  6. 6.1.5 Axonics (Boston Scientific) Recent Developments
  7. 6.2 Neuspera
  8. 6.2.1 Neuspera Company Information
  9. 6.2.2 Neuspera Business Overview
  10. 6.2.3 Neuspera Sacral Neuromodulation Device Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Neuspera Sacral Neuromodulation Device Product Portfolio
  12. 6.2.5 Neuspera Recent Developments
  13. 6.3 General Stim (Nurotron)
  14. 6.3.1 General Stim (Nurotron) Company Information
  15. 6.3.2 General Stim (Nurotron) Business Overview
  16. 6.3.3 General Stim (Nurotron) Sacral Neuromodulation Device Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 General Stim (Nurotron) Sacral Neuromodulation Device Product Portfolio
  18. 6.3.5 General Stim (Nurotron) Recent Developments
  19. 6.4 Medtronic
  20. 6.4.1 Medtronic Company Information
  21. 6.4.2 Medtronic Business Overview
  22. 6.4.3 Medtronic Sacral Neuromodulation Device Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Medtronic Sacral Neuromodulation Device Product Portfolio
  24. 6.4.5 Medtronic Recent Developments
  25. 6.5 PINS Medical
  26. 6.5.1 PINS Medical Company Information
  27. 6.5.2 PINS Medical Business Overview
  28. 6.5.3 PINS Medical Sacral Neuromodulation Device Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 PINS Medical Sacral Neuromodulation Device Product Portfolio
  30. 6.5.5 PINS Medical Recent Developments
7 North America by Country
  1. 7.1 North America Sacral Neuromodulation Device Sales by Country
  2. 7.1.1 North America Sacral Neuromodulation Device Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Sacral Neuromodulation Device Sales by Country (2021-2026)
  4. 7.1.3 North America Sacral Neuromodulation Device Sales Forecast by Country (2027-2032)
  5. 7.2 North America Sacral Neuromodulation Device Market Size by Country
  6. 7.2.1 North America Sacral Neuromodulation Device Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Sacral Neuromodulation Device Market Size by Country (2021-2026)
  8. 7.2.3 North America Sacral Neuromodulation Device Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Sacral Neuromodulation Device Sales by Country
  2. 8.1.1 Europe Sacral Neuromodulation Device Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Sacral Neuromodulation Device Sales by Country (2021-2026)
  4. 8.1.3 Europe Sacral Neuromodulation Device Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Sacral Neuromodulation Device Market Size by Country
  6. 8.2.1 Europe Sacral Neuromodulation Device Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Sacral Neuromodulation Device Market Size by Country (2021-2026)
  8. 8.2.3 Europe Sacral Neuromodulation Device Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Sacral Neuromodulation Device Sales by Country
  2. 9.1.1 Asia-Pacific Sacral Neuromodulation Device Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Sacral Neuromodulation Device Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Sacral Neuromodulation Device Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Sacral Neuromodulation Device Market Size by Country
  6. 9.2.1 Asia-Pacific Sacral Neuromodulation Device Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Sacral Neuromodulation Device Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Sacral Neuromodulation Device Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Sacral Neuromodulation Device Sales by Country
  2. 10.1.1 South America Sacral Neuromodulation Device Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Sacral Neuromodulation Device Sales by Country (2021-2026)
  4. 10.1.3 South America Sacral Neuromodulation Device Sales Forecast by Country (2027-2032)
  5. 10.2 South America Sacral Neuromodulation Device Market Size by Country
  6. 10.2.1 South America Sacral Neuromodulation Device Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Sacral Neuromodulation Device Market Size by Country (2021-2026)
  8. 10.2.3 South America Sacral Neuromodulation Device Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Sacral Neuromodulation Device Sales by Country
  2. 11.1.1 Middle East and Africa Sacral Neuromodulation Device Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Sacral Neuromodulation Device Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Sacral Neuromodulation Device Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Sacral Neuromodulation Device Market Size by Country
  6. 11.2.1 Middle East and Africa Sacral Neuromodulation Device Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Sacral Neuromodulation Device Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Sacral Neuromodulation Device Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Sacral Neuromodulation Device Value Chain Analysis
  2. 12.1.1 Sacral Neuromodulation Device Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Sacral Neuromodulation Device Production Mode & Process
  7. 12.2 Sacral Neuromodulation Device Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Sacral Neuromodulation Device Distributors
  10. 12.2.3 Sacral Neuromodulation Device Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst